Page 35 - OHKF_Biotech_EN

In the past, the mode of I&T collaboration between Hong Kong overseas with Shenzhen’s supply chain to form an industrial
and Shenzhen was often described as basic research by tertiary cluster with complementary advantages. There is therefore not
institutions and research institutes in Hong Kong, followed by the just one mode of HK-SZ collaboration. The two cities need to
deployment of research outcomes by Shenzhen, which utilises its collaborate closely across every stage in the R&D process and
comprehensive supply chain to carry out large-scale production may play different roles in the supply chain of various biotech
of the research outcomes for the huge Mainland market. niches. This chapter will focus on four areas: drugs and vaccines,
However, industrial collaboration between the two cities is no genetic testing and therapies, advanced medical devices and
longer confined to a division of labour along research and application of AI to biotechnology, all of which are important
production lines, nor is it a simple sum of production elements branches of biotech that lend themselves well to existing
and procedures of the two cities. Rather, it is better represented advantages of the two cities. HK-SZ collaboration in these four
as an integration of innovative resources from Hong Kong and areas can be highly valuable.

33